特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
962816

がん診断市場 - 業界分析レポート:地域展望・アプリケーションの成長可能性・価格動向・競合市場シェア & 予測 (2020-2026年)

Cancer Diagnostics Market Size By Application, By Cancer Type, By End-use, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 244 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.41円
がん診断市場 - 業界分析レポート:地域展望・アプリケーションの成長可能性・価格動向・競合市場シェア & 予測 (2020-2026年)
出版日: 2020年09月02日
発行: Global Market Insights Inc.
ページ情報: 英文 244 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のがん診断市場シェアは、世界的ながんの有病率の上昇により、10年ほど前から大幅な拡大を示しています。不健康な食事パターン、喫煙や大量の飲酒を含む座りがちな生活習慣、肥満の増加が、がんの症例数の急増の主な原因です。The American Cancer Societyによると、米国だけで2020年における新規のがん発症者数は180万人、がんによる死亡者数は606,520人が予測されています。

地域の面では、ラテンアメリカにおけるがん診断の市場規模は、2026年までに73億米ドルを上回ると予測されており、地域の政府は新しい診断技術を発見するための研究活動に十分な資金を提供しています。中東・アフリカ (MEA) 地域も、がん診断業界にとって極めて重要な収益源として浮上しています。MEAの市場規模は2019年に8億5,690万米ドルと推計されており、今後数年間で大幅な成長を示す可能性があります。

当レポートでは、がん診断の世界市場について調査分析し、市場の概要、各セグメント・地域別の市場動向、市場規模の推移と予測、市場促進要因および阻害要因の分析、市場の将来展望、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 調査手法

  • 市場の定義
  • 基本推計と作業
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 予測パラメータ
  • データ検証
  • データソース
    • 二次
    • 一次

第2章 エグゼクティブサマリー

  • がん診断市場の全方位的概要
    • 事業動向
    • アプリケーション動向
    • がんタイプ動向
    • エンドユーズ動向
    • 地域動向

第3章 がん診断業界の考察

  • 産業セグメンテーション
  • 業界情勢
  • 業界への影響要因
    • 成長要因
    • 業界の潜在的リスク&課題
  • 成長の可能性の分析
    • アプリケーション別
    • がんタイプ別
    • エンドユーズ別
  • COVID-19の影響分析
  • ポーターの分析
  • 競合情勢
    • 企業のマトリックス分析
  • PESTEL分析

第4章 がん診断市場:アプリケーション別

  • 主要なセグメントの動向
  • 腫瘍バイオマーカーテスト
    • 市場規模:地域別 (金額ベース)
  • イメージング
    • 市場規模:地域別 (金額ベース)
    • 超音波・放射線
    • マンモグラフィ
    • MRIスキャン
    • PETスキャン
    • CTスキャン
    • SPECTなど
  • 生検
  • リキッドバイオプシー
  • 免疫組織化学
  • in situ ハイブリダイゼーション

第5章 がん診断市場:がんタイプ別

  • 主要なセグメントの動向
  • 膀胱がん
    • 市場規模:地域別 (金額ベース)
  • 乳がん
  • 結腸直腸がん
  • 子宮内膜がん
  • 腎臓がん
  • 白血病
  • 肝肺がん
  • 黒色腫
  • 非ホジキンリンパ腫
  • 膵臓がん
  • 前立腺がん
  • 甲状腺がん
  • その他

第6章 がん診断市場:エンドユーズ別

  • 主要なセグメントの動向
  • 病院
    • 市場規模:地域別 (金額ベース)
  • 臨床検査室
  • 画像診断センター
  • がん研究機関

第7章 がん診断市場:地域別

  • 主要な地域の動向
  • 北米
    • 市場規模:国別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:がんタイプ別 (金額ベース)
    • 市場規模:エンドユーズ別 (金額ベース)
    • 米国
    • カナダ
  • 欧州
    • 市場規模:国別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:がんタイプ別 (金額ベース)
    • 市場規模:エンドユーズ別 (金額ベース)
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • ロシア
  • アジア太平洋
    • 市場規模:国別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:がんタイプ別 (金額ベース)
    • 市場規模:エンドユーズ別 (金額ベース)
    • 日本
    • 中国
    • インド
    • オーストラリア
  • 中南米
    • 市場規模:国別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:がんタイプ別 (金額ベース)
    • 市場規模:エンドユーズ別 (金額ベース)
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 市場規模:国別 (金額ベース)
    • 市場規模:アプリケーション別 (金額ベース)
    • 市場規模:がんタイプ別 (金額ベース)
    • 市場規模:エンドユーズ別 (金額ベース)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 企業プロファイル

  • Competitive dashboard, 2019
  • Abbott Laboratories
  • AB Sciex Pte. Ltd
  • Agilent Technologies Inc
  • Becton, Dickinson and Company
  • Biocare Medical LLC
  • Biocartis
  • BioMerieux SA
  • Bio-Rad Laboratories
  • Cancer Genetics Inc
  • GE Healthcare
  • Hologic Inc
  • Janssen Diagnostics LLC (Johnson & Johnson)
  • Leica Biosystem Nussloch GmbH (Danaher Corporation)
  • Myriad Genetics, Inc
  • Qiagen N.V
  • H-Foffmann-La Roche Ltd
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fischer Scientific
図表

Data Tables

  • TABLE 1 Cancer diagnostics industry 360 degree synopsis, 2015 - 2026
  • TABLE 2 Global cancer diagnostics market, 2015 - 2019 (USD Million)
  • TABLE 3 Global cancer diagnostics market, 2020 - 2026 (USD Million)
  • TABLE 4 Global cancer diagnostics market, by application, 2015 - 2019 (USD Million)
  • TABLE 5 Global cancer diagnostics market, by application, 2020 - 2026 (USD Million)
  • TABLE 6 Global cancer diagnostics market, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 7 Global cancer diagnostics market, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 8 Global cancer diagnostics market, by end-use, 2015 - 2019 (USD Million)
  • TABLE 9 Global cancer diagnostics market, by end-use, 2020 - 2026 (USD Million)
  • TABLE 10 Global cancer diagnostics market, by region, 2015 - 2019 (USD Million)
  • TABLE 11 Global cancer diagnostics market, by region, 2020 - 2026 (USD Million)
  • TABLE 12 Industry impact forces
  • TABLE 13 Tumor biomarkers tests market size, by region, 2015 - 2019 (USD Million)
  • TABLE 14 Tumor biomarkers tests market size, by region, 2020 - 2026 (USD Million)
  • TABLE 15 Imaging market size, by region, 2015 - 2019 (USD Million)
  • TABLE 16 Imaging market size, by region, 2020 - 2026 (USD Million)
  • TABLE 17 Ultrasound and radiology market size, by region, 2015 - 2019 (USD Million)
  • TABLE 18 Ultrasound and radiology market size, by region, 2020 - 2026 (USD Million)
  • TABLE 19 Mammography market size, by region, 2015 - 2019 (USD Million)
  • TABLE 20 Mammography market size, by region, 2020 - 2026 (USD Million)
  • TABLE 21 MRI Scan market size, by region, 2015 - 2019 (USD Million)
  • TABLE 22 MRI Scan market size, by region, 2020 - 2026 (USD Million)
  • TABLE 23 PET Scan market size, by region, 2015 - 2019 (USD Million)
  • TABLE 24 PET Scan market size, by region, 2020 - 2026 (USD Million)
  • TABLE 25 CT Scan market size, by region, 2015 - 2019 (USD Million)
  • TABLE 26 CT Scan market size, by region, 2020 - 2026 (USD Million)
  • TABLE 27 SPECT and others market size, by region, 2015 - 2019 (USD Million)
  • TABLE 28 SPECT and others market size, by region, 2020 - 2026 (USD Million)
  • TABLE 29 Biopsy market size, by region, 2015 - 2019 (USD Million)
  • TABLE 30 Biopsy market size, by region, 2020 - 2026 (USD Million)
  • TABLE 31 Liquid biopsy market size, by region, 2015 - 2019 (USD Million)
  • TABLE 32 Liquid biopsy market size, by region, 2020 - 2026 (USD Million)
  • TABLE 33 Immunohistochemistry market size, by region, 2015 - 2019 (USD Million)
  • TABLE 34 Immunohistochemistry market size, by region, 2020 - 2026 (USD Million)
  • TABLE 35 In situ hybridization market size, by region, 2015 - 2019 (USD Million)
  • TABLE 36 In situ hybridization market size, by region, 2020 - 2026 (USD Million)
  • TABLE 37 Bladder cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 38 Bladder cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 39 Breast cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 40 Breast cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 41 Colon and rectal cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 42 Colon and rectal cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 43 Endometrial cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 44 Endometrial cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 45 Kidney cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 46 Kidney cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 47 Leukemia market size, by region, 2015 - 2019 (USD Million)
  • TABLE 48 Leukemia market size, by region, 2020 - 2026 (USD Million)
  • TABLE 49 Liver-lung cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 50 Liver-lung cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 51 Melanoma market size, by region, 2015 - 2019 (USD Million)
  • TABLE 52 Melanoma market size, by region, 2020 - 2026 (USD Million)
  • TABLE 53 Non-Hodgkin lymphoma market size, by region, 2015 - 2019 (USD Million)
  • TABLE 54 Non-Hodgkin lymphoma market size, by region, 2020 - 2026 (USD Million)
  • TABLE 55 Pancreatic cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 56 Pancreatic cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 57 Prostate cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 58 Prostate cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 59 Thyroid cancer market size, by region, 2015 - 2019 (USD Million)
  • TABLE 60 Thyroid cancer market size, by region, 2020 - 2026 (USD Million)
  • TABLE 61 Others market size, by region, 2015 - 2019 (USD Million)
  • TABLE 62 Others market size, by region, 2020 - 2026 (USD Million)
  • TABLE 63 Hospitals market size, by region, 2015 - 2019 (USD Million)
  • TABLE 64 Hospitals market size, by region, 2020 - 2026 (USD Million)
  • TABLE 65 Diagnostic laboratories market size, by region, 2015 - 2019 (USD Million)
  • TABLE 66 Diagnostic laboratories market size, by region, 2020 - 2026 (USD Million)
  • TABLE 67 Diagnostic imaging centers market size, by region, 2015 - 2019 (USD Million)
  • TABLE 68 Diagnostic imaging centers market size, by region, 2020 - 2026 (USD Million)
  • TABLE 69 Cancer research institutes market size, by region, 2015 - 2019 (USD Million)
  • TABLE 70 Cancer research institutes market size, by region, 2020 - 2026 (USD Million)
  • TABLE 71 North America cancer diagnostics market size, by country, 2015 - 2019 (USD Million)
  • TABLE 72 North America cancer diagnostics market size, by country, 2020 - 2026 (USD Million)
  • TABLE 73 North America cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 74 North America cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 75 North America cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 76 North America cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 77 North America cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 78 North America cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 79 North America cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 80 North America cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 81 U.S. cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 82 U.S. cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 83 U.S. cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 84 U.S. cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 85 U.S. cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 86 U.S. cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 87 U.S. cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 88 U.S. cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 89 Canada cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 90 Canada cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 91 Canada cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 92 Canada cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 93 Canada cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 94 Canada cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 95 Canada cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 96 Canada cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 97 Europe cancer diagnostics market size, by country, 2015 - 2019 (USD Million)
  • TABLE 98 Europe cancer diagnostics market size, by country, 2020 - 2026 (USD Million)
  • TABLE 99 Europe cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 100 Europe cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 101 Europe cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 102 Europe cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 103 Europe cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 104 Europe cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 105 Europe cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 106 Europe cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 107 Germany cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 108 Germany cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 109 Germany cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 110 Germany cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 111 Germany cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 112 Germany cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 113 Germany cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 114 Germany cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 115 UK cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 116 UK cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 117 UK cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 118 UK cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 119 UK cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 120 UK cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 121 UK cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 122 UK cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 123 France cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 124 France cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 125 France cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 126 France cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 127 France cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 128 France cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 129 France cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 130 France cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 131 Italy cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 132 Italy cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 133 Italy cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 134 Italy cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 135 Italy cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 136 Italy cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 137 Italy cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 138 Italy cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 139 Russia cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 140 Russia cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 141 Russia cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 142 Russia cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 143 Russia cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 144 Russia cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 145 Russia cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 146 Russia cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 147 Asia Pacific cancer diagnostics market size, by country, 2015 - 2019 (USD Million)
  • TABLE 148 Asia Pacific cancer diagnostics market size, by country, 2020 - 2026 (USD Million)
  • TABLE 149 Asia Pacific cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 150 Asia Pacific cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 151 Asia Pacific cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 152 Asia Pacific cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 153 Asia Pacific cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 154 Asia Pacific cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 155 Asia Pacific cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 156 Asia Pacific cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 157 China cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 158 China cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 159 China cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 160 China cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 161 China cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 162 China Cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 163 China cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 164 China cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 165 India cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 166 India cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 167 India cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 168 India cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 169 India cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 170 India cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 171 India cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 172 India cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 173 Japan cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 174 Japan cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 175 Japan cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 176 Japan cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 177 Japan cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 178 Japan cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 179 Japan cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 180 Japan cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 181 Australia cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 182 Australia cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 183 Australia cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 184 Australia cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 185 Australia cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 186 Australia cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 187 Australia cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 188 Australia cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 189 Latin America cancer diagnostics market size, by country, 2015 - 2019 (USD Million)
  • TABLE 190 Latin America cancer diagnostics market size, by country, 2020 - 2026 (USD Million)
  • TABLE 191 Latin America cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 192 Latin America cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 193 Latin America cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 194 Latin America cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 195 Latin America cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 196 Latin America cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 197 Latin America cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 198 Latin America cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 199 Brazil cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 200 Brazil cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 201 Brazil cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 202 Brazil cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 203 Brazil cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 204 Brazil cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 205 Brazil cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 206 Brazil cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 207 Argentina cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 208 Argentina cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 209 Argentina cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 210 Argentina cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 211 Argentina cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 212 Argentina cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 213 Argentina cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 214 Argentina cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 215 Mexico cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 216 Mexico cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 217 Mexico cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 218 Mexico cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 219 Mexico cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 220 Mexico cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 221 Mexico market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 222 Mexico cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 223 MEA cancer diagnostics market size, by country, 2015 - 2019 (USD Million)
  • TABLE 224 MEA cancer diagnostics market size, by country, 2020 - 2026 (USD Million)
  • TABLE 225 MEA cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 226 MEA cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 227 MEA cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 228 MEA cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 229 MEA cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 230 MEA cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 231 MEA cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 232 MEA cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 233 South Africa cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 234 South Africa cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 235 South Africa cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 236 South Africa cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 237 South Africa cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 238 South Africa cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 239 South Africa cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 240 South Africa cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 241 Saudi Arabia cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 242 Saudi Arabia cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 243 Saudi Arabia cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 244 Saudi Arabia cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 245 Saudi Arabia cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 246 Saudi Arabia cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 247 Saudi Arabia cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 248 Saudi Arabia cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)
  • TABLE 249 UAE cancer diagnostics market size, by application, 2015 - 2019 (USD Million)
  • TABLE 250 UAE cancer diagnostics market size, by application, 2020 - 2026 (USD Million)
  • TABLE 251 UAE cancer diagnostics market size, by imaging, 2015 - 2019 (USD Million)
  • TABLE 252 UAE cancer diagnostics market size, by imaging, 2020 - 2026 (USD Million)
  • TABLE 253 UAE cancer diagnostics market size, by cancer type, 2015 - 2019 (USD Million)
  • TABLE 254 UAE cancer diagnostics market size, by cancer type, 2020 - 2026 (USD Million)
  • TABLE 255 UAE cancer diagnostics market size, by end-use, 2015 - 2019 (USD Million)
  • TABLE 256 UAE cancer diagnostics market size, by end-use, 2020 - 2026 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Cancer diagnostics industry 360 degree synopsis
  • FIG. 4 Industry segmentation
  • FIG. 5 Global cancer diagnostics market, 2015 - 2026 (USD Mn)
  • FIG. 6 Growth potential analysis, by application
  • FIG. 7 Growth potential analysis, by cancer type
  • FIG. 8 Growth potential analysis, by end-use
  • FIG. 9 Porter's analysis
  • FIG. 10 Company matrix analysis, 2019
  • FIG. 11 PESTEL analysis
  • FIG. 12 Key segment trends, by application
  • FIG. 13 Key segment trends, by cancer type
  • FIG. 14 Key segment trends, by end-use
  • FIG. 15 Key regional trends
  • FIG. 16 Competitive dashboard
目次
Product Code: 2406

Title:
Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026.

The global cancer diagnostics market share has been depicting a substantial expansion since the last decade or so on account of the increasing cancer prevalence worldwide. Unhealthy diet patterns, sedentary lifestyles including smoking and extensive alcohol consumption, and rising obesity are majorly responsible for the upsurge in the number of cancer cases. According to the American Cancer Society, here will be an anticipated 1.8 million new cancer cases that would be diagnosed in 2020 and 606,520 deaths from cancer, in the United States alone.

The global cancer diagnostics market has been sub-divided with respect to the application, end-use, cancer type, and regional segments.

With regards to the application landscape, global cancer diagnostics market is categorized into biopsy, imaging, liquid biopsy, imaging, immunohistochemistry, and in-situ hybridization. Of these, the liquid biopsy segment held a market share of 2.6% in 2019. Liquid biopsy - basically tumor analysis using biomarkers present in fluids such as blood, has skyrocketed in popularity since the last decade or so and is on its way to becoming a standard clinical tool. Numerous efforts are underway in this regard - the European Liquid Biopsy Society & US-based BloodPAC project have been working to develop robust and reproducible liquid-biopsy assays.

With respect to the cancer type, global cancer diagnostics market is categorized into breast cancer, melanoma, bladder cancer, kidney cancer, non-Hodgkin lymphoma, colon and rectal cancer, leukemia, endometrial cancer, pancreatic cancer, liver-lung cancer, thyroid cancer, prostate cancer, and others.

Estimates claim that bladder cancer segment held a revenue share of 5.8% in 2019 and may perform exceedingly well on account of the rising cases of bladder cancer and increasing prevalence of smoking which is a known factor raising the risk of bladder cancer.

Non-Hodgkin lymphoma segment may also exhibit appreciable gains. As per Cancer.gov, an estimated 77,240 cases will be detected by 2020 end, with 19,940 deaths - that'll make up for 3.3% of all cancer-related deaths in the year. Based on reliable data, an approximate 2.1 percent of men and women are likely to be diagnosed with non-Hodgkin lymphoma in their lifetime. The robust prevalence of this cancer type and the numerous research programs being undertaken for the development of treatment solutions for the same will push the segmental growth.

With respect to the end-use spectrum, global cancer diagnostics industry has been segmented into cancer research institutes, hospitals, diagnostic laboratories, and diagnostic imaging centers. Of these, the diagnostic imaging centers segment accounted for a market size of USD 17.6 billion in 2019, driven by the fact that these units endorse state-of-the-art equipment and highly trained specialists to perform the necessary tests. Also, they are known to provide results sooner than other avenues.

Regionally, global cancer diagnostics market share spans the zones such as Latin America, the Middle East and Africa, North America, Asia Pacific, and Europe.

Latin America is anticipated to emerge as a lucrative growth ground for cancer diagnostics market, driven by the robust prevalence of cancer in the region. Latin America market is anticipated to cross USD 7.3 billion by 2026, with regional governments providing ample funding for research activities to detect new techniques of diagnosis. Also, the healthcare infrastructure in the region has been developed to a great extent, making it a viable avenue for cancer diagnostics business.

The Middle East and Africa region is also coming up as a pivotal revenue pocket for cancer diagnostics industry. Estimates claim that MEA market size was worth USD 856.9 million in 2019 and may depict substantial growth in the years to come.

Table of Contents

Chapter 1. Methodology

  • 1.1. Market definitions
  • 1.2. Base estimates & working
    • 1.2.1. North America
    • 1.2.2. Europe
    • 1.2.3. Asia Pacific
    • 1.2.4. Latin America
    • 1.2.5. Middle East & Africa
  • 1.3. Forecast parameters
  • 1.4. Data validation
  • 1.5. Data Sources
    • 1.5.1. Secondary
      • 1.5.1.1. Paid sources
      • 1.5.1.2. Unpaid sources
    • 1.5.2. Primary

Chapter 2. Executive Summary

  • 2.1. Cancer diagnostics industry 360 degree synopsis, 2015-2026
    • 2.1.1. Business trends
    • 2.1.2. Application trends
    • 2.1.3. Cancer type trends
    • 2.1.4. End-use trends
    • 2.1.5. Regional trends

Chapter 3. Cancer Diagnostics Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2015 - 2026
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Rising incidence of cancer globally
      • 3.3.1.2. Several initiatives undertaken by government and other organizations to spread disease awareness
      • 3.3.1.3. Growing number of diagnostic laboratories in developed countries
      • 3.3.1.4. Technological advancements in developed countries
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. High capital investment coupled with high cost associated with diagnostic imaging system
      • 3.3.2.2. Risk related with high radiation exposure affecting use of CT scanner
  • 3.4. Growth potential analysis
    • 3.4.1. By application
    • 3.4.2. By cancer type
    • 3.4.3. By end-use
  • 3.5. COVID-19 impact analysis
  • 3.6. Porter's analysis
  • 3.7. Competitive landscape
    • 3.7.1. Company matrix analysis, 2019
  • 3.8. PESTEL analysis

Chapter 4. Cancer Diagnostics Market, By Application

  • 4.1. Key segment trends
  • 4.2. Tumor biomarkers tests
    • 4.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.3. Imaging
    • 4.3.1. Market size, by region, 2015 - 2026 (USD Million)
    • 4.3.2. Ultrasound and radiology
      • 4.3.2.1. Market size, by region, 2015 - 2026 (USD Million)
    • 4.3.3. Mammography
      • 4.3.3.1. Market size, by region, 2015 - 2026 (USD Million)
    • 4.3.4. MRI scan
      • 4.3.4.1. Market size, by region, 2015 - 2026 (USD Million)
    • 4.3.5. PET scan
      • 4.3.5.1. Market size, by region, 2015 - 2026 (USD Million)
    • 4.3.6. CT scan
      • 4.3.6.1. Market size, by region, 2015 - 2026 (USD Million)
    • 4.3.7. SPECT & others
      • 4.3.7.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.4. Biopsy
    • 4.4.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.5. Liquid biopsy
    • 4.5.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.6. Immunohistochemistry
    • 4.6.1. Market size, by region, 2015 - 2026 (USD Million)
  • 4.7. In situ hybridization
    • 4.7.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 5. Cancer Diagnostics Market, By Cancer type

  • 5.1. Key segment trends
  • 5.2. Bladder cancer
    • 5.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.3. Breast cancer
    • 5.3.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.4. Colon and rectal cancer
    • 5.4.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.5. Endometrial cancer
    • 5.5.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.6. Kidney cancer
    • 5.6.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.7. Leukemia
    • 5.7.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.8. Liver-lung cancer
    • 5.8.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.9. Melanoma
    • 5.9.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.10. Non-Hodgkin lymphoma
    • 5.10.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.11. Pancreatic cancer
    • 5.11.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.12. Prostate cancer
    • 5.12.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.13. Thyroid cancer
    • 5.13.1. Market size, by region, 2015 - 2026 (USD Million)
  • 5.14. Others
    • 5.14.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 6. Cancer Diagnostics Market, By End-use

  • 6.1. Key segment trends
  • 6.2. Hospitals
    • 6.2.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.3. Diagnostic laboratories
    • 6.3.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.4. Diagnostic imaging centers
    • 6.4.1. Market size, by region, 2015 - 2026 (USD Million)
  • 6.5. Cancer research institutes
    • 6.5.1. Market size, by region, 2015 - 2026 (USD Million)

Chapter 7. Cancer Diagnostics Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.2.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.2.2.1. Market size, by imaging, 2015 - 2026 (USD Million)
    • 7.2.3. Market size, by cancer type, 2015 - 2026 (USD Million)
    • 7.2.4. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.2.5.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.2.5.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.2.5.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.2.6.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.2.6.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.2.6.3. Market size, by end-use, 2015 - 2026 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.3.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.3.2.1. Market size, by imaging, 2015 - 2026 (USD Million)
    • 7.3.3. Market size, by cancer type, 2015 - 2026 (USD Million)
    • 7.3.4. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.3.5.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.3.5.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.3.5.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.3.6. UK
      • 7.3.6.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.3.6.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.3.6.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.3.6.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.3.7. France
      • 7.3.7.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.3.7.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.3.7.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.3.7.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.3.8.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.3.8.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.3.8.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.3.9. Russia
      • 7.3.9.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.3.9.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.3.9.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.3.9.3. Market size, by end-use, 2015 - 2026 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.4.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.4.2.1. Market size, by imaging, 2015 - 2026 (USD Million)
    • 7.4.3. Market size, by cancer type, 2015 - 2026 (USD Million)
    • 7.4.4. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.4.5. Japan
      • 7.4.5.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.4.5.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.4.5.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.4.5.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.4.6. China
      • 7.4.6.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.4.6.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.4.6.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.4.6.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.4.7.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.4.7.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.4.7.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.4.8.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.4.8.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.4.8.3. Market size, by end-use, 2015 - 2026 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.5.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.5.2.1. Market size, by imaging, 2015 - 2026 (USD Million)
    • 7.5.3. Market size, by cancer type, 2015 - 2026 (USD Million)
    • 7.5.4. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.5.5.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.5.5.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.5.5.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.5.6.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.5.6.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.5.6.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.5.7.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.5.7.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.5.7.3. Market size, by end-use, 2015 - 2026 (USD Million)
  • 7.6. MEA
    • 7.6.1. Market size, by country, 2015 - 2026 (USD Million)
    • 7.6.2. Market size, by application, 2015 - 2026 (USD Million)
      • 7.6.2.1. Market size, by imaging, 2015 - 2026 (USD Million)
    • 7.6.3. Market size, by cancer type, 2015 - 2026 (USD Million)
    • 7.6.4. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.6.5.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.6.5.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.6.5.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.6.6. Saudi Arabia
      • 7.6.6.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.6.6.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.6.6.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.6.6.3. Market size, by end-use, 2015 - 2026 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by application, 2015 - 2026 (USD Million)
        • 7.6.7.1.1. Market size, by imaging, 2015 - 2026 (USD Million)
      • 7.6.7.2. Market size, by cancer type, 2015 - 2026 (USD Million)
      • 7.6.7.3. Market size, by end-use, 2015 - 2026 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Competitive dashboard, 2019
  • 8.2. Abbott Laboratories
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. AB Sciex Pte. Ltd
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Agilent Technologies Inc
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Becton, Dickinson and Company
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Biocare Medical LLC
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Biocartis
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. BioMerieux SA
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Bio-Rad Laboratories
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Cancer Genetics Inc
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. GE Healthcare
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Hologic Inc
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Janssen Diagnostics LLC (Johnson & Johnson)
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
  • 8.14. Leica Biosystem Nussloch GmbH (Danaher Corporation)
    • 8.14.1. Business overview
    • 8.14.2. Financial data
    • 8.14.3. Product landscape
    • 8.14.4. Strategic outlook
    • 8.14.5. SWOT analysis
  • 8.15. Myriad Genetics, Inc
    • 8.15.1. Business overview
    • 8.15.2. Financial data
    • 8.15.3. Product landscape
    • 8.15.4. Strategic outlook
    • 8.15.5. SWOT analysis
  • 8.16. Qiagen N.V
    • 8.16.1. Business overview
    • 8.16.2. Financial data
    • 8.16.3. Product landscape
    • 8.16.4. Strategic outlook
    • 8.16.5. SWOT analysis
  • 8.17. H-Foffmann-La Roche Ltd
    • 8.17.1. Business overview
    • 8.17.2. Financial data
    • 8.17.3. Product landscape
    • 8.17.4. Strategic outlook
    • 8.17.5. SWOT analysis
  • 8.18. Siemens Healthineers
    • 8.18.1. Business overview
    • 8.18.2. Financial data
    • 8.18.3. Product landscape
    • 8.18.4. Strategic outlook
    • 8.18.5. SWOT analysis
  • 8.19. Sysmex Corporation
    • 8.19.1. Business overview
    • 8.19.2. Financial data
    • 8.19.3. Product landscape
    • 8.19.4. Strategic outlook
    • 8.19.5. SWOT analysis
  • 8.20. Thermo Fischer Scientific
    • 8.20.1. Business overview
    • 8.20.2. Financial data
    • 8.20.3. Product landscape
    • 8.20.4. Strategic outlook
    • 8.20.5. SWOT analysis
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.